News
-
-
COMMUNIQUÉ DE PRESSE
Biophytis Reports First-Half 2025 Results and Provides Strategic Update
Biophytis reports financial results for the first half of 2025, strategic update, and key achievements in sarcopenia and obesity. Plans for Phase 2 and Phase 3 studies outlined with focus on sustaining growth and value creation -
-
COMMUNIQUÉ DE PRESSE
Apex Completes Non-Brokered Private Placement for Proceeds of $10,000,000
Apex Critical Metals Corp. completes $10M non-brokered private placement, issuing 4,000,000 Units at $2.50 per Unit for general working capital and exploration expenses. Advances rare earth element and niobium projects in the US and Canada -
-
-
COMMUNIQUÉ DE PRESSE
Goldcliff Closes First Tranche of Private Placement and Finalizes Plans for Drill Site Preparation at Kettle Valley
Goldcliff Resource Corporation announces the closing of the first tranche of its non-brokered private placement of 1,900,000 flow-through shares for drilling at Kettle Valley and Ainsworth silver project in British Columbia -
-
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies -
COMMUNIQUÉ DE PRESSE
DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration
DBV Technologies nomme Philina Lee, Ph.D. au Conseil d’administration et Comité des rémunérations. Lee apporte son expertise en biopharmaceutique et commercialisation. DBV se concentre sur le traitement des allergies alimentaires
